Lindbrook Capital, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,442
-2.0%
200.0%0.00%
Q1 2023$1,471
-70.6%
20
-65.5%
0.00%
-100.0%
Q3 2022$5,000
+400.0%
58
+205.3%
0.00%
Q1 2020$1,000
-50.0%
190.0%0.00%
-100.0%
Q4 2019$2,0000.0%190.0%0.00%0.0%
Q3 2019$2,000
-75.0%
19
-75.0%
0.00%
-66.7%
Q2 2019$8,000
-11.1%
760.0%0.00%
-25.0%
Q1 2019$9,000
-10.0%
760.0%0.00%
-20.0%
Q4 2018$10,000760.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders